Market research
1302.HK LifeTech Scientific Corporation
HK HKD Healthcare
Latest close
As of 30 Oct 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 7B
- P/E ratio
- 152.0
- Analyst target
- 2.7814
- Dividend yield
- Not available
- Beta
- 0.31
Profile
Instrument facts
- Exchange
- HK
- Currency
- HKD
- Sector
- Healthcare
- Industry
- Medical Devices
- ISIN
- KYG548721177
- Market cap
- 7B
- P/E ratio
- 152.0
- Analyst target
- 2.7814
- Dividend yield
- Not available
- Beta
- 0.31
About
About LifeTech Scientific Corporation
LifeTech Scientific Corporation, an investment holding company, develops, manufactures, and trades in interventional medical devices for cardiovascular and peripheral vascular diseases and disorders in Mainland China, Europe, Rest of Asia, India, South America, Africa, and internationally. It operates through Structural Heart Diseases Business, Peripheral Vascular Diseases Business, and Cardiac Pacing and Electrophysiology Business segments. It is also involved in biomedical research and development; properties leasing business; and developing, manufacturing, and trading of medical devices, as well as offers technical, consulting, and technology services. LifeTech Scientific Corporation was founded in 1999 and is headquartered in Shenzhen, China.
Research context
LifeTech Scientific Corporation appears in PyInvesting’s Hong Kong Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- HKD
- Sector
- Healthcare
- Industry
- Medical Devices
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the 1302.HK discussion.
5 years, 7 months ago
LifeTech Scientific Corporation is currently in a long term uptrend where the price is trading 26.9% above its 200 day moving average.
From a valuation standpoint, the stock is 81.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 21.0.
LifeTech Scientific Corporation's total revenue sank by 24.3% to $273M since the same quarter in the previous year.
Its net income has increased by 168.7% to $99M since the same quarter in the previous year.
Finally, its free cash flow grew by 355.8% to $53M since the same quarter in the previous year.
Based on the above factors, LifeTech Scientific Corporation gets an overall score of 4/5.